Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for high-throughput synthesis of monoclonal antibody stably transfected expression cell strain

A technology of monoclonal antibody and cell line, applied in anti-cytokine/lymphokine/interferon immunoglobulin, chemical instruments and methods, botany equipment and methods, etc. Problems such as large differences in antibody expression can be achieved to improve the success rate, stable production, and easy operation

Pending Publication Date: 2021-05-28
ZHEJIANG ZHENGXI BIOMEDICAL CO LTD
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The disadvantages of this traditional method are: (1) Since the fusion transformation rate of B cells and tumor cells is not 100%, many B cells that can recognize the target antigen during the fusion process cannot obtain these clones through the above method due to fusion failure; (2) The hybridoma cells themselves are relatively unstable, and the antibody expression levels of different hybridoma cells vary greatly, and the target antibody is easy to be lost after multiple passages; (3) Monoclonal target antibody screening after the synthesis of hybridoma cells will consume A lot of manual work, and to a certain extent, whether hybridoma cells targeting the target antigen can be obtained depends on luck, and the success rate of obtaining positive clones by traditional methods is not high
Although the above two methods have obtained cell lines stably expressing the corresponding monoclonal antibodies, since one immunogen was used to immunize one animal in the early stage, there were fewer types of spleen B cells obtained, and the success of obtaining the target antigen antibody rate is also lower

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for high-throughput synthesis of monoclonal antibody stably transfected expression cell strain
  • Method for high-throughput synthesis of monoclonal antibody stably transfected expression cell strain
  • Method for high-throughput synthesis of monoclonal antibody stably transfected expression cell strain

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] A method for high-throughput synthesis of monoclonal antibody stably expressing cell lines, comprising the steps of:

[0032] 1. Acquisition of antigen (immunogen)

[0033] Human IL6 recombinant protein antigen was purchased from Invitrogen (Thermo Scientific).

[0034] 2. Immunize mice, rats, and rabbits with immunogens

[0035] (1) Immunization dosage of Balb / c mice and rats: the dosage of immunization is 100 μg / small (big) mouse, and the immunization period is 14 days. The tail vein was used to boost immunization; the immune adjuvants were Freund's complete adjuvant and Freund's incomplete adjuvant (both purchased from Sigma).

[0036] (2) Rabbit immunization dose: choose big-eared white rabbits with a monthly age of 3 months and a weight of 1.5 kg, and raise them in a standard animal room, observe them for three consecutive days, and perform immunization after confirming that the condition is normal. Immunization was carried out by multi-point subcutaneous inject...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for high-throughput synthesis of a monoclonal antibody stably transfected expression cell strain. The method comprises the following steps: S1, preparing a target antigen and immunizing an animal by adopting the target antigen; S2, after the immunization is completed, taking the animal spleen, screening out memory B cells and plasma cells by adopting a flow cytometry, and preparing a single-cell suspension; S3, carrying out amplification reverse transcription on mRNA of the single cell to synthesize cDNA, amplifying variable regions of a heavy chain and a light chain of an antibody, and respectively connecting the variable regions to a carrier; and S4, carrying out cell transfection to obtain the monoclonal antibody stably transfected expression cell strain. Compared with a traditional hybridoma cell strain, the cell strain prepared by the method disclosed by the invention is stable, the batch-to-batch production of secreted antibodies is stable, the yield is 10-50 times higher than that of the hybridoma cell strain, and the cell strain can be widely applied to industrial production.

Description

technical field [0001] The invention relates to the technical field of monoclonal antibody preparation, in particular to a method for high-throughput synthesis of monoclonal antibody stably transfected expression cell lines. Background technique [0002] The traditional monoclonal antibody preparation method is to immunize animals such as mice or rabbits with antigens, and then perform single-cell screening by fusing spleen B cells with tumor cells (S / p20) to obtain hybridomas that secrete the target antigen. cell. The disadvantages of this traditional method are: (1) Since the fusion transformation rate of B cells and tumor cells is not 100%, many B cells that can recognize the target antigen during the fusion process cannot obtain these clones through the above method due to fusion failure; (2) The hybridoma cells themselves are relatively unstable, and the antibody expression levels of different hybridoma cells vary greatly, and the target antibody is easy to be lost aft...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/10C12N15/13C12N15/85C07K16/24
CPCC07K16/246C07K16/248C12N15/85
Inventor 张洋黄爽茹
Owner ZHEJIANG ZHENGXI BIOMEDICAL CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products